Complicaciones neurológicas relacionadas con la inmunoterapia en pacientes oncológicos

Abstract

Immune checkpoint inhibitors, better known as immunotherapies, have revolutionized oncological treatment, allowing long-lasting and even curative tumor responses in various neoplasms. Their use, however, is associated with immunological adverse effects, among which neurological adverse effects represent a rare but clinically relevant entity.

This article addresses the epidemiology, classification, diagnostic keys and management of the most frequent neurological complications of immunotherapies, providing health professionals, and especially neurologists, with key tools for their recognition and timely treatment.